HCA Healthcare, Inc. (NYSE:HCA) Shares Acquired by First Horizon Advisors Inc.

First Horizon Advisors Inc. boosted its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 2.4% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,532 shares of the company’s stock after buying an additional 36 shares during the quarter. First Horizon Advisors Inc.’s holdings in HCA Healthcare were worth $623,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Bangor Savings Bank lifted its position in shares of HCA Healthcare by 112.5% in the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after acquiring an additional 45 shares in the last quarter. MFA Wealth Advisors LLC acquired a new position in HCA Healthcare during the second quarter valued at $27,000. Unique Wealth Strategies LLC purchased a new position in HCA Healthcare during the 2nd quarter valued at about $28,000. GPS Wealth Strategies Group LLC grew its position in HCA Healthcare by 284.0% during the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after purchasing an additional 71 shares in the last quarter. Finally, Benjamin F. Edwards & Company Inc. purchased a new position in shares of HCA Healthcare during the 2nd quarter valued at $33,000. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Stock Performance

HCA Healthcare stock opened at $332.22 on Friday. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. The stock’s 50 day moving average is $380.80 and its 200 day moving average is $357.94. HCA Healthcare, Inc. has a twelve month low of $245.84 and a twelve month high of $417.14. The company has a market capitalization of $84.15 billion, a P/E ratio of 14.92, a PEG ratio of 1.29 and a beta of 1.68.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.79%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare’s payout ratio is currently 11.85%.

Insiders Place Their Bets

In other news, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the transaction, the senior vice president now owns 52,702 shares in the company, valued at $18,445,700. This trade represents a 6.89 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the transaction, the insider now directly owns 6,843 shares in the company, valued at approximately $2,415,579. This represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 15,155 shares of company stock valued at $5,608,990. 1.60% of the stock is owned by insiders.

Analysts Set New Price Targets

HCA has been the topic of several research reports. Royal Bank of Canada upped their target price on HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research report on Friday, August 23rd. Barclays decreased their target price on shares of HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating for the company in a research report on Friday, November 8th. TD Cowen lowered their target price on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. Wells Fargo & Company raised their price objective on HCA Healthcare from $395.00 to $400.00 and gave the company an “equal weight” rating in a research note on Wednesday, November 6th. Finally, StockNews.com downgraded HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. Five research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and a consensus price target of $385.00.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.